• Strategic Sourcing Advisory

    Evaluation and Recommendation for Strategic IT Managed Services. The client engaged Proj3ctS to conduct a comprehensive evaluation of its Application Development & Management contract. The objective was to assess the current outsourcing agreement (including service…

    Read more: Strategic Sourcing Advisory
  • Empowering Ambits with Scalable Back-Office Automation

    Proj3ctS enables Ambits to scale with a future-proof, low-code solution that halves administrative costs and enhances user experience. Ambits, a fast-growing Belgian startup specializing in leadership mentoring, faced a significant challenge: a manual, inefficient back-office…

    Read more: Empowering Ambits with Scalable Back-Office Automation
  • If it doesn't happen, make it happen

    IT Transformation

    Situation The organization faced significant challenges in its IT department, including leadership challenges, lack of ownership, unclear vision, and excessive governance structures. These issues hindered our ability to innovate and respond to market demands effectively.…

    Read more: IT Transformation
  • Bringing the medicine to patients

    Transforming from biotech to biopharma

    Creating a new value chain to serve unmet patient needs đź’ˇOperation built from scratch: process, systems and data. But foremost on the “make-it-happen” spirit of the people đź’ˇChange is the only constant in life: Assume…

    Read more: Transforming from biotech to biopharma
  • End-to-end automation Galapagos Journey

    End-to-End Automation

    On the CIO Forum in September 2021 I had the opportunity to present about End-to-End automation at Galapagos. Key take-away’s “The Galapagos organization has learned to deliver faster & more efficient with People & Process…

    Read more: End-to-End Automation
  • IT Project Cost Management: going from Biotech to Pharma

    Key learnings and insights from the session with ISPE COP for Projectmanagement: Full presentation

    Read more: IT Project Cost Management: going from Biotech to Pharma